NVSEF - Novartis AG (NVS) CEO Vas Narasimhan on Q2 2021 Results - Earnings Call Transcript
Novartis AG (NVS) Q2 2021 Earnings Conference Call July 21, 2021 8:00 a.m. ET Company Participants Samir Shah - Global Head of Investor Relations Vas Narasimhan - Chief Executive Officer Marie-France - President of Novartis Pharmaceuticals Susanne Schaffert - President of Novartis Oncology Harry Kirsch - CFO John Tsai - Head of Global Drug Development and Chief Medical Officer for Novartis Conference Call Participants Wimal Kapadia - Bernstein Graham Parry - Bank of America Jo Walton - Credit Suisse Andrew Baum - Citi Mario Purcell - Morgan Stanley Emmanuel Papadakis - Deutsche Bank Richard Parkes - Exane BNP Seamus Fernandez - Guggenheim Kerry Holford - Berenberg Peter Welford - Jefferies Laura Sutcliffe - UBS Tim Anderson - Wolfe Research Simon Baker - Redburn Steve Scala - Cowen & Company Naresh Chouhan - Intron Health Keyur Parekh - Goldman Sachs Presentation Operator Good morning and good afternoon, and welcome to the
For further details see:
Novartis AG (NVS) CEO Vas Narasimhan on Q2 2021 Results - Earnings Call Transcript